03.02.2022 • NewsSiburTechnip FMC

Sibur Selects Technip Energies as 1-Hexene Licensor

Russian petrochemicals giant Sibur has chosen French engineering company Technip Energies as the licensor of its 1-hexene technology, known as Hexsib. The technology was developed by NIOST, one of Sibur’s main R&D centers.

Sibur said it expects that the alliance with Technip Energies will “produce license agreements with international polyolefin makers and integrate the technology into complex design solutions to build new manufacturing capacities for advanced PE grades.”

Used in the production of HDPE and LLDPE, 1-hexene is a co-monomer that enhances the resins’ quality and properties versus commodity grades. For example, using 1-hexene can reduce the amount of plastic and lower the grade’s environmental footprint by providing the same barrier properties in a thinner film.

Darya Borisova, a member of Sibur's management board and head of R&D, commented: “Sibur is currently selecting a site within the group's range of facilities for production of hexene-1 with the Hexsib technology to satisfy its own and market needs as the company expands its portfolio of high value grades and share of co-monomers.”

Author: Elaine Burridge, Freelance Journalist

(c) Technip Energies
(c) Technip Energies

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.